| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |